Robert L. Fine, M.D., is the Herbert Irving Associate Professor of Medicine and Director of Experimental Therapeutics at the Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center. Dr. Fine specializes in caring for patients with pancreatic cancer, neuroendocrine cancers, untreatable tumors and brain tumors. His expertise lies in creating new experimental therapies for his laboratory and translating them directly to the clinic population. Dr. Fine received his B.A. and B.S. degrees in Philosophy and BioChemistry and finished medical school at the University of Chicago Pritzker School of Medicine where he graduated with research honors. He conducted his internal medicine training at Stanford University Hospital and did a medical oncology fellowship at the National Cancer Institute, National Institutes of Health, where he stayed on faculty for an additional three years in experimental pharmacology. He then spent six years at Duke University Cancer Center as an Assistant Professor of Medicine before coming to Columbia in 1996.
University of Chicago Pritzker School of Medicine
Internship: Stanford Hospital & Clinics
Residency: Stanford Hospital & Clinics
Fellowship: National Cancer Institute